Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Sponsor: Medical University of South Carolina
Terminated
Failure to reach study enrollment milestones
Other terminated trials from Medical University of South Carolina
- Bleeding Esophageal Varices · Phase PHASE4 · Dec 2024
- Prostate Cancer · Phase PHASE2 · Aug 2024
- Intrathecal Morphine · Phase PHASE4 · May 2024
- Blood Pressure · Phase NA · Feb 2024
- Non-Small Cell Lung Cancer · Phase PHASE1/PHASE2 · Dec 2023
See all terminations from Medical University of South Carolina
Other Breast Cancer trials with similar outcome
This PHASE4 trial investigates Breast Cancer and Insomnia and is currently terminated or withdrawn. Medical University of South Carolina leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Oct 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Oct 2024 — Oct 2025 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE4
▶ Show 4 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2024 — Jun 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2024 — Apr 2024 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of South Carolina
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .